Skip to main content

Plaque Psoriasis News (Page 5)

FDA Approves Otezla (apremilast) for Moderate to Severe Plaque Psoriasis

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (apremilast), the Company's oral, selective inhibitor of...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Psoriasis

Related drug support groups

methylprednisolone, Humira, Enbrel, Remicade, Otezla, Stelara, Cosentyx, Skyrizi, adalimumab, dexamethasone, etanercept, halobetasol, Taltz